Woodbine Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Woodbine Capital Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$1.32M	Buy	+25,000	New	+$1.16M	1.32%	15

Other funds holding TEVA

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Woodbine Capital Advisors's TEVA Position: Q1 2014 in Review

Woodbine Capital Advisors opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2014: 25,000 shares worth $1.32M. The stake represents 1.32% of the portfolio and ranks #15 among its holdings.

771 funds tracked by Wall St. Rank hold TEVA as of Q1 2014.

Woodbine Capital Advisors held 25,000 shares of Teva Pharmaceuticals worth $1.32M as of Q1 2014.
Teva Pharmaceuticals was a new Woodbine Capital Advisors position in Q1 2014.
Teva Pharmaceuticals made up 1.32% of Woodbine Capital Advisors's portfolio in Q1 2014, its #15 holding.
771 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2014.

Based on Woodbine Capital Advisors's 13F filing for Q1 2014, filed 15 May 2014.